HAL Id: hal-03249243
https://hal.archives-ouvertes.fr/hal-03249243
Submitted on 7 Jun 2021
HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Distributed under a Creative Commons Attribution - NonCommercial| 4.0 International
New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in
different tumor models
Alessandra Lopes, Chiara Bastiancich, Mathilde Bausart, Sophie Ligot, Laure Lambricht, Kevin Vanvarenberg, Bernard Ucakar, Bernard Gallez, Véronique
Préat, Gaëlle Vandermeulen
To cite this version:
Alessandra Lopes, Chiara Bastiancich, Mathilde Bausart, Sophie Ligot, Laure Lambricht, et al.. New
generation of DNA-based immunotherapy induces a potent immune response and increases the survival
in different tumor models. Journal for Immunotherapy of Cancer, BMJ Publishing Group 2021, 9 (4),
pp.e001243. �10.1136/jitc-2020-001243�. �hal-03249243�
New generation of DNA- based immunotherapy induces a potent immune response and increases the survival in different tumor models
Alessandra Lopes,
1Chiara Bastiancich ,
1,2Mathilde Bausart,
1Sophie Ligot,
1Laure Lambricht,
1Kevin Vanvarenberg,
1Bernard Ucakar,
1Bernard Gallez,
3Véronique Préat,
1Gaëlle Vandermeulen
1To cite: Lopes A, Bastiancich C, Bausart M, et al. New generation of DNA- based immunotherapy induces a potent immune response and increases the survival in different tumor models. Journal for ImmunoTherapy of Cancer 2021;9:e001243. doi:10.1136/
jitc-2020-001243
►
Prepublication history and additional material is published online only. To view please visit the journal online (http:// dx. doi.
org/ 10. 1136/ jitc- 2020- 001243).
AL and CB contributed equally.
Accepted 02 March 2021
1
Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université catholique de Louvain, Brussels, Belgium
2
Aix- Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France
3